The company is significantly boosted its development of the new treatment for ATTR-CM, employing the compound. Initial trial data suggests potential benefits for individuals suffering from the serious disease. The focus https://attruby024327.blogacep.com/47788070/bridgebio-advances-amyloidosis-management-through-the-drug